The Pathogenesis and Treatment Progress of Androgenic Alopecia
January 2024
in “
Journal of Biosciences and Medicines
”
androgenic alopecia hair follicle miniaturization androgen metabolism minoxidil 5α-reductase inhibitors Wnt/β-catenin pathway WNT10A APCDDI MSC-derived exosomes WNT3 miR-221 IGF-1 hair follicle stem cells AGA Rogaine 5-alpha-reductase inhibitors Wnt pathway mesenchymal stem cell-derived exosomes insulin-like growth factor 1
Studysummary This research suggests that recent discoveries of signaling pathways in androgenic alopecia may pave the way for targeted therapies, providing potential new treatment options beyond the current FDA-approved drugs, minoxidil and finasteride.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on scirp.org →